Price-gouging pharma bro under investigation for corporate looting, fraud and stalking

This isn’t the first time Martin Shkreli, the most hated man on the Internet, has attracted criticism for his unscrupulous business dealings.
Shkreli has ignited a firestorm after purchasing the rights to Daraprim, a 62-year-old drug used for treating life-threatening parasitic infections in babies and AIDS patients, and raising the price overnight from $13.50 per tablet to $750.
He gave an interview Monday to Bloomberg, which has taken a “special interest” in the 32-year-old Shkreli after the “self-trained biologist” dramatically changed his position on biotech futures.
READ MORE:http://www.rawstory.com/2015/09/price-gouging-pharma-bro-under-investigation-for-corporate-looting-fraud-and-stalking/